HIV-1-IN-82
HIV-1-IN-82 (Compound L14) is an orally active small-molecule entry inhibitor for HIV-1 with an IC50 value of 0.39 μM. HIV-1 inhibitor-82 is promising for research of anti-HIV-1 infection[1].
Product Specifications
CAS Number
[43099-56-5]
UNSPSC
12352005
Target
HIV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
ClC1=CC=C(C(C2=CC=C(N(CC3=CC(S(O)(=O)=O)=CC=C3)CC)C=C2)C4=CC=C(N(CC5=CC(S(O)(=O)=O)=CC=C5)CC)C=C4)C=C1
Molecular Formula
C37H37ClN2O6S2
Molecular Weight
705.28
References & Citations
[1]Liang R, et al. Design, synthesis and biological evaluation of novel triarylmethane analogues as HIV-1 entry inhibitors. Eur J Med Chem. 2025 Apr 8;291:117574.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1220777-01 0.02 mg (E-Coli)
Recombinant Postia placenta Nuclear distribution protein PAC1-2 (PAC1-2)
Ask
View Details MBS1220777-02 0.02 mg (Yeast)
Recombinant Postia placenta Nuclear distribution protein PAC1-2 (PAC1-2)
Ask
View Details 
MBS1220777-03 0.1 mg (E-Coli)
Recombinant Postia placenta Nuclear distribution protein PAC1-2 (PAC1-2)
Ask
View Details 
MBS1220777-04 0.1 mg (Yeast)
Recombinant Postia placenta Nuclear distribution protein PAC1-2 (PAC1-2)
Ask
View Details MBS1220777-05 0.02 mg (Baculovirus)
Recombinant Postia placenta Nuclear distribution protein PAC1-2 (PAC1-2)
Ask
View Details